Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 27.55%4.49B | -30.60%1.23B | -34.45%554.33M | -28.61%4.58B | -14.51%3.52B | -32.30%1.77B | -45.71%845.61M | -12.60%6.42B | 33.08%4.12B | 85.22%2.62B |
| Refunds of taxes and levies | 25.99%159.51M | -7.50%61M | ---- | 144.69%156.36M | 100.36%126.6M | 16.39%65.95M | -32.72%36.08M | -90.23%63.9M | -90.27%63.19M | -90.92%56.66M |
| Cash received relating to other operating activities | -31.42%116.35M | -23.18%75.09M | -27.97%44.03M | -26.04%217.12M | -9.94%169.65M | -17.76%97.74M | 16.74%61.13M | 48.93%293.58M | 45.12%188.37M | 76.89%118.85M |
| Cash inflows from operating activities | 24.88%4.77B | -29.44%1.37B | -36.53%598.36M | -26.86%4.96B | -12.65%3.82B | -30.69%1.94B | -43.32%942.81M | -17.31%6.78B | 12.80%4.37B | 32.72%2.79B |
| Goods services cash paid | -60.59%511.12M | -74.41%257.26M | -59.64%269.57M | -46.54%1.38B | -27.90%1.3B | -17.66%1.01B | 69.01%667.94M | 61.57%2.58B | 12.46%1.8B | 44.79%1.22B |
| Staff behalf paid | -7.41%239.72M | 3.32%167.43M | -0.11%85.79M | -6.67%401.19M | -0.10%258.9M | -1.82%162.05M | -0.93%85.89M | 8.96%429.88M | 21.40%259.17M | 18.87%165.05M |
| All taxes paid | -5.21%667.25M | -2.07%430.42M | -1.21%177.2M | -2.38%960.02M | 0.24%703.95M | 2.25%439.52M | 8.76%179.37M | 24.30%983.44M | 30.66%702.23M | 52.54%429.84M |
| Cash paid relating to other operating activities | 17.21%271.51M | 12.54%162.12M | -16.82%65.72M | -19.76%328.21M | -18.42%231.63M | -16.89%144.05M | 6.15%79.01M | 28.69%409.04M | 32.48%283.95M | 26.52%173.32M |
| Cash outflows from operating activities | -32.19%1.69B | -41.90%1.02B | -40.89%598.28M | -30.29%3.07B | -18.16%2.49B | -11.98%1.75B | 40.34%1.01B | 41.99%4.4B | 18.69%3.04B | 41.99%1.99B |
| Net cash flows from operating activities | 132.11%3.08B | 88.87%348.35M | 100.11%77.93K | -20.51%1.89B | -0.01%1.33B | -77.04%184.43M | -107.36%-69.39M | -53.37%2.38B | 1.28%1.33B | 14.25%803.33M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -65.52%1.2B | -96.30%100M | ---- | -64.35%3.48B | -56.29%3.48B | -51.46%2.7B | -47.75%1.16B | 187.12%9.76B | 1,227.03%7.96B | --5.56B |
| Cash received from returns on investments | -83.47%3.56M | -98.97%156.16K | ---- | -61.20%21.54M | -51.22%21.54M | -54.27%15.17M | -44.22%7.8M | 81.61%55.52M | 540.63%44.17M | 1,015.12%33.17M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,251.28%124.18M | -93.08%314.38K | -94.05%270.4K | -45.45%6.71M | -55.69%5.28M | -61.23%4.54M | -60.99%4.54M | 137.92%12.31M | 11,047.25%11.92M | 11,436.66%11.72M |
| Net cash received from disposal of subsidiaries and other business units | --362.49K | ---- | ---- | --0 | ---- | ---- | ---- | -84.19%1.08M | -84.19%1.08M | -84.19%1.08M |
| Cash received relating to other investing activities | 889.69%19.25M | -83.47%321.5K | ---- | --7.77M | --1.95M | --1.95M | ---- | --0 | ---- | ---- |
| Cash inflows from investing activities | -61.60%1.35B | -96.30%100.79M | -99.98%270.4K | -64.24%3.52B | -56.25%3.51B | -51.47%2.72B | -47.82%1.17B | 183.96%9.83B | 1,166.15%8.02B | 18,947.90%5.61B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 28.51%2.97B | 34.21%2.22B | -4.81%894.74M | 13.52%3.63B | 14.80%2.31B | 70.07%1.65B | 171.07%939.95M | 47.10%3.2B | 123.04%2.01B | 84.24%971.32M |
| Cash paid to acquire investments | -31.58%1.3B | -63.16%700M | ---- | -78.01%1.9B | -74.12%1.9B | -64.43%1.9B | -52.63%900M | 41.30%8.64B | 78.48%7.34B | --5.34B |
| Net cash paid to acquire subsidiaries and other business units | 737.02%132.26M | 2,089.12%132.26M | 106.58%12.48M | 67.80%89.8M | -70.47%15.8M | -88.71%6.04M | -87.60%6.04M | -42.29%53.51M | -42.29%53.51M | --53.51M |
| Cash paid relating to other investing activities | -96.21%281.94K | -95.80%252K | ---- | --9.46M | --7.43M | --6M | ---- | --0 | ---- | ---- |
| Cash outflows from investing activities | 3.97%4.4B | -14.43%3.05B | -50.85%907.23M | -52.67%5.63B | -55.00%4.23B | -44.02%3.56B | -19.58%1.85B | 41.87%11.89B | 84.16%9.41B | 1,107.69%6.37B |
| Net cash flows from investing activities | -321.47%-3.05B | -250.08%-2.95B | -34.63%-906.95M | -2.46%-2.11B | 47.82%-724.59M | -11.00%-842.32M | -1,280.81%-673.65M | 58.10%-2.06B | 68.97%-1.39B | -52.46%-758.87M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -56.76%15.5M | -68.69%10.16M | -71.73%7.22M | 91.27%54.32M | 35.78%35.85M | --32.45M | --25.54M | -99.52%28.4M | -99.56%26.4M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --24.5M | -36.55%16.75M | --15.25M | --15M | --0 | --26.4M | ---- |
| Cash from borrowing | 18.39%6.16B | 63.07%5.74B | -2.53%1.4B | 36.02%6.81B | 40.50%5.2B | 39.95%3.52B | 156.26%1.44B | -13.71%5.01B | -19.38%3.7B | -40.16%2.52B |
| Cash received relating to other financing activities | ---- | ---- | ---- | --170.03M | --38.48M | --1.48M | --1.48M | --0 | ---- | --0 |
| Cash inflows from financing activities | 17.01%6.17B | 61.80%5.75B | -3.83%1.41B | 39.71%7.03B | 41.50%5.28B | 41.30%3.56B | 161.07%1.47B | -58.09%5.04B | -65.10%3.73B | -41.82%2.52B |
| Borrowing repayment | 3.07%4.21B | -17.09%2.41B | -42.54%785.84M | -12.05%5.35B | -22.83%4.09B | -33.56%2.91B | -18.14%1.37B | -18.36%6.09B | -12.98%5.3B | 13.94%4.38B |
| Dividend interest payment | -16.27%856.67M | 60.24%525.54M | 81.17%293.83M | 6.32%1.17B | 7.13%1.02B | -60.95%327.98M | -13.38%162.18M | -10.39%1.1B | 55.99%955.01M | 94.09%839.83M |
| Cash payments relating to other financing activities | -6.82%307.52M | 19.87%209.04M | 37.84%163.78M | 127.39%709.46M | 19.24%330.02M | 4.05%174.39M | 181.52%118.82M | -2.96%312M | 37.10%276.76M | 32.53%167.6M |
| Cash outflows from financing activities | -1.16%5.38B | -7.77%3.15B | -24.58%1.24B | -3.56%7.23B | -16.66%5.44B | -36.66%3.41B | -13.23%1.65B | -16.73%7.5B | -5.39%6.53B | 22.34%5.39B |
| Net cash flows from financing activities | 585.11%796.73M | 1,737.02%2.6B | 192.93%168.09M | 92.05%-195.82M | 94.13%-164.24M | 104.93%141.75M | 86.48%-180.88M | -181.74%-2.46B | -173.96%-2.8B | -3,472.42%-2.87B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -21.46%1.24M | 21.95%1.6M | -94.42%66.63K | 213.47%1.48M | 161.04%1.58M | 563.63%1.31M | 1,079.95%1.19M | -622.00%-1.3M | -4,696.45%-2.59M | 162.01%197.61K |
| Net increase in cash and cash equivalents | 87.31%821.85M | 101.00%5.17M | 19.94%-738.72M | 80.58%-417M | 115.32%438.77M | 81.80%-514.83M | -107.59%-922.73M | -167.32%-2.15B | -562.88%-2.86B | -2,369.56%-2.83B |
| Add:Begin period cash and cash equivalents | -17.91%1.91B | -17.91%1.91B | -17.91%1.91B | -47.98%2.33B | -47.98%2.33B | -47.98%2.33B | -47.98%2.33B | 248.11%4.48B | 248.11%4.48B | 248.11%4.48B |
| End period cash equivalent | -1.23%2.73B | 5.68%1.92B | -16.58%1.17B | -17.91%1.91B | 71.70%2.77B | 10.08%1.81B | -65.14%1.41B | -47.98%2.33B | -15.38%1.61B | 16.80%1.65B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhitong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.